0 results for 'Cigna'
Antitrust Class Actions Against CVS, Other Pharmacy Benefit Managers Are Piling Up
Plaintiffs, independent pharmacies, claimed the defendants "have vertically integrated" with health care giants such as insurance companies, health care providers, drug private labelers and others. As a result, the complaints say, pharmacy benefits managers use anticompetitive methods to suppress reimbursements for discount card payments, which allegedly causes stand-alone pharmacies to suffer and even go out of business.A New Era of Enforcement on 10b5-1 Trading Plans: Implications of United States v. Peizer
The authors write "This past June the U.S. Department of Justice (DOJ) secured its first insider trading conviction relating to the defendant’s use of a Rule 10b5-1 trading plan. The jury’s verdict in United States v. Peizer marks a major milestone in securities law enforcement. In particular, the Peizer case puts pressure on the defense that 10b5-1 plans provided corporate insiders. Separately, the verdict suggests a new era of enforcement priorities and tactics, and provides instructive insights for practitioners and professionals."New York Financial Services Watchdog Adopts Rules to Rein In Prescription Benefit Managers
New York State Department of Financial Services Superintendent Adrienne Harris said new regulations will help protect New Yorkers’ access to prescription drugs, prohibit business practices that increase the cost of those drugs, and ensure that small, independent pharmacies compete on a level playing field with large pharmacies affiliated with pharmacy benefit managers, who decide the availability of prescription drugs and their costs.Corporate Counsel's 2024 Award Winners Performed Legal Wizardry, Gave a Hand Up to Others
Honorees received their trophies on Nov. 13 at The American Lawyer Industry Awards in New York City.View more book results for the query "Cigna"
Litigator of the Week Runners-Up and Shout-Outs
Runners-up this week include trial teams at Patterson Belknap and Susman Godfrey.Antitrust at a Crossroads: How the 2024 Election Could Shift the Economic Balance
"Despite both candidates keeping policy cards close, one truth remains clear from the history: Antitrust scrutiny will persist, regardless of who wins," writes Joey Seeber, CEO of Level Legal.Express Scripts' Defamation Case Against FTC Will Fall Short, Law Professor Says
"It's not uncommon that a defamation suit is brought, not necessarily because the plaintiff expects to take it to trial, but instead, because they want to make a public announcement that what was said about them is wrong," said Lyrissa Lidsky, a University of Florida law professor.FTC Takes Legal Action Against Three Largest PBMs Over High Insulin Prices
"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed," said Rahul Rao, deputy director of the FTC's Bureau of Competition.Lamont Nominates Attorney Kathleen Unger Holt State's Healthcare Advocate
Holt founded a Seattle-area law practice to advocate for the needs of older people and people who have disabilities. She led this practice until her arrival at the Center for Medicare Advocacy.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Why Embracing Change Is Essential for Your Legal Department
Brought to you by DiliTrust
Download Now
International Export and Trade Assistance State Law Survey
Brought to you by LexisNexis®
Download Now
How This Personal Injury Firm Reduced Client Intake Time by 80%
Brought to you by PracticePanther
Download Now
The Hidden Cost of Bad Reviews: Why Law Firms & Attorneys Can't Afford a Damaged Online Reputation
Brought to you by Erase.com
Download Now